These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38171046)

  • 1. Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosis.
    Fujimori J; Nakashima I
    J Neuroimmunol; 2024 Feb; 387():578280. PubMed ID: 38171046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
    Uher T; Vaneckova M; Krasensky J; Sobisek L; Tyblova M; Volna J; Seidl Z; Bergsland N; Dwyer MG; Zivadinov R; De Stefano N; Sormani MP; Havrdova EK; Horakova D
    Mult Scler; 2019 Apr; 25(4):541-553. PubMed ID: 29143562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validation study of manual atrophy measures in patients with Multiple Sclerosis.
    Cappelle S; Pareto D; Tintoré M; Vidal-Jordana A; Alyafeai R; Alberich M; Sastre-Garriga J; Auger C; Montalban X; Rovira À
    Neuroradiology; 2020 Aug; 62(8):955-964. PubMed ID: 32246177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of regional brain volume loss in multiple sclerosis: a cluster analysis.
    Fujimori J; Fujihara K; Ogawa R; Baba T; Wattjes M; Nakashima I
    J Neurol; 2020 Feb; 267(2):395-405. PubMed ID: 31654116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced Quantitative MRI Unveils Microstructural Thalamic Changes Reflecting Disease Progression in Multiple Sclerosis.
    Cagol A; Ocampo-Pineda M; Lu PJ; Weigel M; Barakovic M; Melie-Garcia L; Chen X; Lutti A; Calabrese P; Kuhle J; Kappos L; Sormani MP; Granziera C
    Neurol Neuroimmunol Neuroinflamm; 2024 Nov; 11(6):e200299. PubMed ID: 39270143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain atrophy patterns in multiple sclerosis patients treated with natalizumab and its clinical correlates.
    Rekik A; Aissi M; Rekik I; Mhiri M; Frih MA
    Brain Behav; 2022 May; 12(5):e2573. PubMed ID: 35398999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients.
    Kalinowska-Lyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Bus K; Leszczynski P; Puszczewicz M; Paprzycki W; Kozubski W; Michalak S
    Lupus; 2018 Sep; 27(10):1624-1635. PubMed ID: 29950159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.
    Granberg T; Bergendal G; Shams S; Aspelin P; Kristoffersen-Wiberg M; Fredrikson S; Martola J
    J Neuroimaging; 2015; 25(6):996-1001. PubMed ID: 25786805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-Based Manual versus Automated Corpus Callosum Volumetric Measurements in Multiple Sclerosis.
    Platten M; Martola J; Fink K; Ouellette R; Piehl F; Granberg T
    J Neuroimaging; 2020 Mar; 30(2):198-204. PubMed ID: 31750599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical and white matter lesion topology influences focal corpus callosum atrophy in multiple sclerosis.
    Platten M; Ouellette R; Herranz E; Barletta V; Treaba CA; Mainero C; Granberg T
    J Neuroimaging; 2022 May; 32(3):471-479. PubMed ID: 35165979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies.
    Lomer NB; Asalemi KA; Saberi A; Sarlak K
    PLoS One; 2024; 19(4):e0300415. PubMed ID: 38626023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis.
    Lee H; Nakamura K; Narayanan S; Brown RA; Nash RA; Griffith LM; Steinmiller KC; Devine SM; Hutton GJ; Popat U; Racke MK; Georges GE; Bowen JD; Arnold DL
    Mult Scler Relat Disord; 2021 Sep; 54():103149. PubMed ID: 34284316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grey matter atrophy in patients with benign multiple sclerosis.
    Niiranen M; Koikkalainen J; Lötjönen J; Selander T; Cajanus A; Hartikainen P; Simula S; Vanninen R; Remes AM
    Brain Behav; 2022 Jul; 12(7):e2679. PubMed ID: 35765699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corpus callosum atrophy--a simple predictor of multiple sclerosis progression: a longitudinal 9-year study.
    Vaneckova M; Kalincik T; Krasensky J; Horakova D; Havrdova E; Hrebikova T; Seidl Z
    Eur Neurol; 2012; 68(1):23-7. PubMed ID: 22677920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between brain volume loss and disability in multiple sclerosis: A systematic review.
    Matthews PM; Gupta D; Mittal D; Bai W; Scalfari A; Pollock KG; Sharma V; Hill N
    Mult Scler Relat Disord; 2023 Jun; 74():104714. PubMed ID: 37068369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-dimensional measurements with cut-off values are useful for assessing brain volume, physical disability, and processing speed in multiple sclerosis.
    Nishizawa K; Fujimori J; Nakashima I
    Mult Scler Relat Disord; 2022 Mar; 59():103543. PubMed ID: 35078126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis.
    Storelli L; Pagani E; Meani A; Preziosa P; Filippi M; Rocca MA
    J Neurol; 2022 Sep; 269(9):4729-4741. PubMed ID: 35397753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalamic asymmetry in Multiple Sclerosis.
    Ramezani N; Davanian F; Naghavi S; Riahi R; Zandieh G; Danesh-Mobarhan S; Ashtari F; Shaygannejad V; Sanayei M; Adibi I
    Mult Scler Relat Disord; 2023 Sep; 77():104853. PubMed ID: 37473593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis.
    Uher T; Krasensky J; Sobisek L; Seidl Z; Bergsland N; Dwyer MG; Kubala Havrdova E; Zivadinov R; Horakova D; Vaneckova M
    J Neuroimaging; 2018 May; 28(3):328-337. PubMed ID: 29485230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.